Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

Symmans et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d8e8a62c39562886ae3260 — DOI: https://doi.org/10.1200/jco.2007.10.6823

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome· 2007 · 306 citations
2. Resampling and cross-validation techniques: a tool to reduce bias caused by model building?· 1997 · 142 citations
3. Regression Modeling Strategies· 2001 · 9,255 citations
4. Assessing the Generalizability of Prognostic Information· 1999 · 1,191 citations
5. Pathological assessment of response to induction chemotherapy in breast cancer.· 1986 · 341 citations